AI Business
1d ago
Pharmaceutical Industry Invests in AI for Drug Development Amid Uncertain Outcomes
May 18, 2026
AI Summary
The pharmaceutical sector is increasingly investing in artificial intelligence to streamline drug development processes. Despite the potential for faster and more predictable outcomes, the effectiveness of these AI-driven treatments remains uncertain, as traditional methods have long been costly and time-consuming.
- The average cost to develop a drug and gain FDA approval is over $1 billion and takes about a decade.
- Approximately 90% of drugs do not make it through all stages of clinical trials.
- Traditional drug discovery involves formulating a hypothesis and conducting numerous tests to identify effective compounds, which is often a lengthy process.
- The pharmaceutical industry is now exploring AI technologies to enhance the efficiency and predictability of drug development.
aidrug developmentbig pharmahealthcaretechnology